Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With Osteoporosis

17. November 2026 aktualisiert von: Riphah International University

Effects of Sensorimotor-Based Balance Training Versus Digitally Augmented Core Stabilization on Postural Control and Fall Risk in Postmenopausal Women With Osteoporosis

This randomized controlled trial aims to compare the effects of sensorimotor-based balance training and digitally augmented core stabilization on postural control and fall risk in postmenopausal women with osteoporosis. Osteoporosis is a common condition in postmenopausal women that can impair balance, reduce functional mobility, and increase the risk of falls and fractures. Eligible participants will be randomly assigned to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, while Group B will receive a digitally augmented core stabilization exercise program supported through the HEP2Go platform and monitored via WhatsApp. Both groups will receive supervised physiotherapy sessions three times per week for 8 weeks. Outcome measures including postural control, fall risk, spinal alignment, core muscle endurance, proprioception, muscle strength, adherence, and usability will be assessed before and after the intervention. The findings of this study may provide evidence regarding effective physiotherapy strategies for improving balance and reducing fall risk in postmenopausal women with osteoporosis.

Studienübersicht

Detaillierte Beschreibung

Osteoporosis is a progressive skeletal disorder characterized by reduced bone mineral density and deterioration of bone microarchitecture, resulting in increased bone fragility and susceptibility to fractures. Postmenopausal women are particularly affected because estrogen deficiency accelerates bone loss, leading to impaired postural stability, reduced muscle strength, proprioceptive deficits, and an increased risk of falls. Falls are a major cause of morbidity, disability, and reduced quality of life among women with osteoporosis.

Exercise-based physiotherapy is an important non-pharmacological intervention for improving balance, postural control, muscle strength, and functional mobility in individuals with osteoporosis. Sensorimotor-based balance training aims to improve proprioception, neuromuscular coordination, and postural stability through progressively challenging balance and functional activities. Core stabilization exercises focus on strengthening deep trunk muscles to improve spinal stability, posture, and movement control.

Digital rehabilitation technologies have increasingly been incorporated into physiotherapy practice to improve exercise adherence, accessibility, and patient engagement. In this study, digital augmentation will be delivered through the HEP2Go platform by providing individualized home exercise programs with exercise illustrations and written instructions. Participants in the digitally augmented group will also receive regular follow-up and adherence monitoring through WhatsApp communication with the assistance of caregivers.

This study will be conducted as a randomized controlled trial involving postmenopausal women diagnosed with osteoporosis. Eligible participants who satisfy the inclusion criteria and provide written informed consent will undergo baseline assessment and then be randomly allocated to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, whereas Group B will receive a digitally augmented core stabilization exercise program. Both interventions will be administered three times per week for 8 weeks.

Primary outcomes include postural control and fall risk. Secondary outcomes include thoracic kyphosis angle, core muscle endurance, lumbar joint position sense, trunk extensor strength, exercise adherence, and system usability. Outcome measures will be recorded before and after completion of the intervention using standardized assessment tools. Data will be analyzed using SPSS version 26 to compare within-group and between-group changes.

Studientyp

Interventionell

Einschreibung (Geschätzt)

40

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Hadia D/O Shahid Hassan Siddiqui, DPT
  • Telefonnummer: +92 305-5085595
  • E-Mail: hadiadr2000@gmail.com

Studienorte

    • Federal
      • Islamabad, Federal, Pakistan, 44000
        • Rekrutierung
        • Muhammad Adnan Saeed
        • Kontakt:
          • Muhammad Adnan Saeed, PhD
          • Telefonnummer: +93219565124
          • E-Mail: dasnmc@gmail.com

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

45 Jahre bis 70 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Weiblich

Beschreibung

Inclusion Criteria:

  • PMW diagnosed with osteoporosis through DEXA (T-score ≤ -2.5)
  • Age (45-70 years).
  • Able to participate in sessions and walk independently.
  • Mild to moderate Balance impairment as per BBS

Exclusion Criteria:

  • • Women with severe mobility impairments.

    • History of fragility fracture within the last 6 months
    • Women with cognitive conditions affecting participation.
    • Women with lower limb joint injury or surgery.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Sensorimotor-Based Balance Training

Participants assigned to this arm will receive a structured sensorimotor-based balance training program aimed at improving postural control, proprioception, balance, and reducing fall risk in postmenopausal women with osteoporosis. The intervention consists of warm-up exercises, static and dynamic balance training, sensorimotor and proprioceptive exercises, gait and functional training, lower-limb strengthening exercises, and cool-down activities. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks, with progressive exercise intensity according to participant tolerance.

A supervised sensorimotor-based balance training program comprising progressive static and dynamic balance exercises, proprioceptive training, gait training, lower-limb strengthening, functional balance activities, and cool-down exercises. Sessions will be conducted three times per week for 8-12 weeks to improve postural control, balance, and functional mobility in postmenopausal women with osteoporosis.

Experimental: Digitally Augmented Core Stabilization

Participants assigned to this arm will receive a structured core stabilization exercise program enhanced through digital augmentation using the HEP2Go platform. Individualized home exercise programs containing exercise illustrations and written instructions will be provided through HEP2Go. The intervention includes warm-up, deep core muscle activation, core stabilization exercises, functional core training, postural training, and cool-down exercises. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks. Exercise adherence and progress will be monitored through regular WhatsApp communication with participants and their caregivers.

A supervised core stabilization exercise program focusing on activation and strengthening of deep trunk muscles, postural alignment, and functional stability. Digital augmentation will be provided through the HEP2Go platform by delivering individualized home exercise programs with exercise illustrations and written instructions. Participants will also receive regular WhatsApp reminders, educational support, and adherence monitoring throughout the 8-12-week intervention period.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postural Control (Mini-BESTest)
Zeitfenster: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Postural control will be assessed using the Mini-Balance Evaluation Systems Test (Mini-BESTest), a 14-item clinical measure of postural control. Total scores range from 0 to 28 points, with higher scores indicating better postural control.

Baseline (pre-intervention) and immediately after completion of the 8-week intervention.
Fall Risk
Zeitfenster: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Fall risk will be assessed using the Timed Up and Go (TUG) Test. Time is recorded in seconds, with shorter completion times indicating better functional mobility and lower fall risk.

Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Thoracic Kyphosis Angle
Zeitfenster: Baseline and immediately after completion of the 8-week intervention.

Thoracic kyphosis angle will be measured using a Flexicurve ruler.

Baseline and immediately after completion of the 8-week intervention.
Core Muscle Endurance
Zeitfenster: Baseline and immediately after completion of the 8-week intervention

core muscle endurance will be assessed using the Modified McGill Trunk Endurance Test.

Baseline and immediately after completion of the 8-week intervention
Proprioception
Zeitfenster: Baseline and immediately after completion of the 8-week intervention.

Lumbar proprioception will be assessed using the lumbar joint position sense repositioning error test.

Baseline and immediately after completion of the 8-week intervention.
Trunk Extensor Muscle Strength
Zeitfenster: Baseline and immediately after completion of the 8-week intervention.

Trunk extensor muscle strength will be measured using a handheld dynamometer.

Baseline and immediately after completion of the 8-week intervention.
Exercise Adherence
Zeitfenster: Throughout the 8-week intervention period.

Exercise adherence will be evaluated using attendance records and home exercise adherence logs throughout the intervention period.

Throughout the 8-week intervention period.
System Usability
Zeitfenster: At the end of the 8-week intervention.

System usability of the digitally augmented intervention will be assessed using the System Usability Scale (SUS). The SUS consists of 10 items and provides a total score ranging from 0 to 100 points, with higher scores indicating better perceived usability of the digitally augmented intervention.

At the end of the 8-week intervention.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Huma Riaz, Riphah International University, Islamabad

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

19. Oktober 2026

Primärer Abschluss (Geschätzt)

30. Juni 2027

Studienabschluss (Geschätzt)

31. Juli 2027

Studienanmeldedaten

Zuerst eingereicht

16. September 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

11. Oktober 2026

Zuerst gepostet (Tatsächlich)

15. Oktober 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

17. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data (IPD) will not be shared publicly because the dataset contains confidential participant information collected for an academic research project. Data will be stored securely and used only for the purposes of this study. Any future sharing of de-identified data will require approval from the Institutional Review Board/Ethics Committee and the principal investigator, in accordance with institutional policies and participant consent.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren